Name | {[2-{4-[(R)-(4-Chlorophenyl)(phenyl)methyl]-1-piperazinyl}(2H4)ethyl]oxy}acetic acid |
---|---|
Synonyms |
Acetic acid, 2-[[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethyl-1,1,2,2-d4]oxy]-
{[2-{4-[(R)-(4-Chlorophenyl)(phenyl)methyl]-1-piperazinyl}(2H4)ethyl]oxy}acetic acid |
Description | Levocetirizine-d4 ((R)-Cetirizine-d4) is the deuterium-labeled Levocetirizine (HY-B0814)[1]. Levocetirizine ((R)-Cetirizine) is a third-generation peripheral H1-receptor antagonist. Levocetirizine is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria[2]. |
---|---|
Related Catalog | |
In Vitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注,因为它可能影响药物的药代动力学和代谢谱[1]。 |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 542.1±45.0 °C at 760 mmHg |
Molecular Formula | C21H21D4ClN2O3 |
Molecular Weight | 392.91 |
Flash Point | 281.6±28.7 °C |
Exact Mass | 392.180481 |
LogP | 2.16 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.589 |